Psoriasis Completed Phase Trials for Mesalazine (DB00244)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02376478On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection